Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. / Redondo, Pilar; Prieto, Jesús; Muñoz, Inés G; Alibés, Andreu; Stricher, Francois; Serrano, Luis; Cabaniols, Jean-Pierre; Daboussi, Fayza; Arnould, Sylvain; Perez, Christophe; Duchateau, Philippe; Pâques, Frédéric; Blanco, Francisco J; Montoya, Guillermo.
In: Nature, Vol. 456, No. 7218, 06.11.2008, p. 107-11.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases
AU - Redondo, Pilar
AU - Prieto, Jesús
AU - Muñoz, Inés G
AU - Alibés, Andreu
AU - Stricher, Francois
AU - Serrano, Luis
AU - Cabaniols, Jean-Pierre
AU - Daboussi, Fayza
AU - Arnould, Sylvain
AU - Perez, Christophe
AU - Duchateau, Philippe
AU - Pâques, Frédéric
AU - Blanco, Francisco J
AU - Montoya, Guillermo
PY - 2008/11/6
Y1 - 2008/11/6
N2 - Xeroderma pigmentosum is a monogenic disease characterized by hypersensitivity to ultraviolet light. The cells of xeroderma pigmentosum patients are defective in nucleotide excision repair, limiting their capacity to eliminate ultraviolet-induced DNA damage, and resulting in a strong predisposition to develop skin cancers. The use of rare cutting DNA endonucleases-such as homing endonucleases, also known as meganucleases-constitutes one possible strategy for repairing DNA lesions. Homing endonucleases have emerged as highly specific molecular scalpels that recognize and cleave DNA sites, promoting efficient homologous gene targeting through double-strand-break-induced homologous recombination. Here we describe two engineered heterodimeric derivatives of the homing endonuclease I-CreI, produced by a semi-rational approach. These two molecules-Amel3-Amel4 and Ini3-Ini4-cleave DNA from the human XPC gene (xeroderma pigmentosum group C), in vitro and in vivo. Crystal structures of the I-CreI variants complexed with intact and cleaved XPC target DNA suggest that the mechanism of DNA recognition and cleavage by the engineered homing endonucleases is similar to that of the wild-type I-CreI. Furthermore, these derivatives induced high levels of specific gene targeting in mammalian cells while displaying no obvious genotoxicity. Thus, homing endonucleases can be designed to recognize and cleave the DNA sequences of specific genes, opening up new possibilities for genome engineering and gene therapy in xeroderma pigmentosum patients whose illness can be treated ex vivo.
AB - Xeroderma pigmentosum is a monogenic disease characterized by hypersensitivity to ultraviolet light. The cells of xeroderma pigmentosum patients are defective in nucleotide excision repair, limiting their capacity to eliminate ultraviolet-induced DNA damage, and resulting in a strong predisposition to develop skin cancers. The use of rare cutting DNA endonucleases-such as homing endonucleases, also known as meganucleases-constitutes one possible strategy for repairing DNA lesions. Homing endonucleases have emerged as highly specific molecular scalpels that recognize and cleave DNA sites, promoting efficient homologous gene targeting through double-strand-break-induced homologous recombination. Here we describe two engineered heterodimeric derivatives of the homing endonuclease I-CreI, produced by a semi-rational approach. These two molecules-Amel3-Amel4 and Ini3-Ini4-cleave DNA from the human XPC gene (xeroderma pigmentosum group C), in vitro and in vivo. Crystal structures of the I-CreI variants complexed with intact and cleaved XPC target DNA suggest that the mechanism of DNA recognition and cleavage by the engineered homing endonucleases is similar to that of the wild-type I-CreI. Furthermore, these derivatives induced high levels of specific gene targeting in mammalian cells while displaying no obvious genotoxicity. Thus, homing endonucleases can be designed to recognize and cleave the DNA sequences of specific genes, opening up new possibilities for genome engineering and gene therapy in xeroderma pigmentosum patients whose illness can be treated ex vivo.
KW - Animals
KW - CHO Cells
KW - Cell Line
KW - Cricetinae
KW - Cricetulus
KW - Crystallography, X-Ray
KW - DNA/chemistry
KW - DNA Repair
KW - DNA Restriction Enzymes/chemistry
KW - DNA-Binding Proteins/genetics
KW - Enzyme Stability
KW - Genetic Engineering
KW - Humans
KW - Models, Molecular
KW - Phosphorylation
KW - Protein Multimerization
KW - Substrate Specificity
KW - Xeroderma Pigmentosum/genetics
U2 - 10.1038/nature07343
DO - 10.1038/nature07343
M3 - Journal article
C2 - 18987743
VL - 456
SP - 107
EP - 111
JO - Nature
JF - Nature
SN - 0028-0836
IS - 7218
ER -
ID: 245614763